相似文献
1
Correction: The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials.
PLoS Med. 2016 Jun 24;13(6):e1002091. doi: 10.1371/journal.pmed.1002091. eCollection 2016 Jun.
2
Correction: Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
PLoS Med. 2020 Dec 29;17(12):e1003517. doi: 10.1371/journal.pmed.1003517. eCollection 2020 Dec.
3
Correction: Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
PLoS Med. 2016 Jun 10;13(6):e1002064. doi: 10.1371/journal.pmed.1002064. eCollection 2016 Jun.
4
Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
PLoS Med. 2016 Jun 3;13(6):e1002050. doi: 10.1371/journal.pmed.1002050. eCollection 2016 Jun.
5
Correction: All-Cause Mortality of Low Birthweight Infants in Infancy, Childhood, and Adolescence: Population Study of England and Wales.
PLoS Med. 2016 Jun 15;13(6):e1002069. doi: 10.1371/journal.pmed.1002069. eCollection 2016 Jun.
6
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.
Diabetes Obes Metab. 2013 Oct;15(10):938-53. doi: 10.1111/dom.12116. Epub 2013 May 13.
7
Correction: Active or Passive Exposure to Tobacco Smoking and Allergic Rhinitis, Allergic Dermatitis, and Food Allergy in Adults and Children: A Systematic Review and Meta-Analysis.
PLoS Med. 2016 Feb 2;13(2):e1001939. doi: 10.1371/journal.pmed.1001939. eCollection 2016 Feb.
8
Correction: intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
PLoS Med. 2015 Mar 31;12(3):e1001818. doi: 10.1371/journal.pmed.1001818. eCollection 2015 Mar.
9
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS Med. 2016 Jun 10;13(6):e1002066. doi: 10.1371/journal.pmed.1002066. eCollection 2016 Jun.
10
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS Med. 2016 Apr 5;13(4):e1002009. doi: 10.1371/journal.pmed.1002009. eCollection 2016 Apr.
引用本文的文献
1
Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review.
Diabetes Ther. 2024 Aug;15(8):1687-1716. doi: 10.1007/s13300-024-01612-8. Epub 2024 Jun 27.
2
Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
Int J Heart Fail. 2023 Jan 24;5(1):1-20. doi: 10.36628/ijhf.2022.0028. eCollection 2023 Jan.
3
Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
Diabetes Metab J. 2023 Jan;47(1):10-26. doi: 10.4093/dmj.2022.0420. Epub 2023 Jan 26.
4
Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
Endocrinol Metab (Seoul). 2022 Jun;37(3):415-429. doi: 10.3803/EnM.2022.304. Epub 2022 Jun 29.
5
Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia.
J Alzheimers Dis. 2022;86(1):245-257. doi: 10.3233/JAD-215337.
6
Changing the approach to type 2 diabetes treatment: A comparison of glucagon-like peptide-1 receptor agonists and sulphonylureas across the continuum of care.
Diabetes Metab Res Rev. 2021 Oct;37(7):e3434. doi: 10.1002/dmrr.3434. Epub 2021 Feb 7.
7
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
Indian J Endocrinol Metab. 2020 Jan-Feb;24(1):1-122. doi: 10.4103/ijem.IJEM_225_20.
8
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus.
Diabetol Metab Syndr. 2020 May 24;12:45. doi: 10.1186/s13098-020-00551-1. eCollection 2020.
9
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.
Circ Res. 2020 May 22;126(11):1526-1548. doi: 10.1161/CIRCRESAHA.119.316065. Epub 2020 May 21.
10
The impact of glucose-lowering medications on cardiovascular disease.
Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):13-17. doi: 10.1097/XCE.0000000000000139. eCollection 2018 Mar.
本文引用的文献
1
The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials.
PLoS Med. 2016 Apr 12;13(4):e1001992. doi: 10.1371/journal.pmed.1001992. eCollection 2016 Apr.
Zotero 插件